Interplaying Factors That Effect Multiple Sclerosis Causation and Sustenance

Table 2

Concentrations of mimotopic peptide constructs used in application to individual microplate test wells are listed alongside each construct sequence. The basic procedure is described in Section 2.

Microgram of mimotopic peptide construct per milliliter of coating buffer for MS test microplate wells
Peptide amino Acid Sequence of amino-ADOOA-ADOOA-peptide Construct ADOOA-peptide construct	Peptide Construct μg/mL Concentration	Construct molar mass (kilodaltons)
(1) ADARM	0.26	0.56
(2) HSYQE	0.31	0.66
(3) RNVRF	0.33	0.69
(4) VTLRI	0.28	0.6
(5) IENLH	0.29	0.62
(6) NLHRTFFE	0.5	1.06
(7) KTGQF	0.27	0.58
(8) DNTFKD	0.39	0.82
(9) HGRTQ	0.28	0.6
(10) LQTIQE	0.34	0.73
(11) PKNAW	0.34	0.73
(12) QDTAVT	0.3	0.63
(13) YKDSHHPA	0.45	0.95
(14) DNEVFGEA	0.5	0.9